Cargando…
Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study
BACKGROUND: Mantle cell lymphoma (MCL) with co-expression of CD10 and BCL-6 was scarcely reported, and its biological features were largely remained unknown. Thus, this study aimed to describe the clinical and biological features, as well as outcome of MCL patients with co-expression of CD10 and BCL...
Autores principales: | Chen, Wanzi, Liu, Hangmin, Wang, Pengcheng, Li, Guoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798977/ https://www.ncbi.nlm.nih.gov/pubmed/35116331 http://dx.doi.org/10.21037/tcr-21-882 |
Ejemplares similares
-
Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review
por: Castillo, Dani Ran, et al.
Publicado: (2023) -
The distinct clinical features and prognosis of the CD10(+)MUM1(+) and CD10(−)Bcl6(−)MUM1(−) diffuse large B-cell lymphoma
por: Lu, Ting-Xun, et al.
Publicado: (2016) -
Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature
por: Hino, Christopher, et al.
Publicado: (2022) -
Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011) -
Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma
por: Chiron, David, et al.
Publicado: (2015)